X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Bafna Pharmaceuticals Ltd.
BSE CODE: 532989   |   NSE CODE: BAFNAPH   |   ISIN CODE : INE878I01022   |   13-May-2024 Hrs IST
BSE NSE
Rs. 99.75
0 ( 0% )
 
Prev Close ( Rs.)
99.75
Open ( Rs.)
99.75
 
High ( Rs.)
99.75
Low ( Rs.)
99.75
 
Volume
15
Week Avg.Volume
9591
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 99.60
0 ( 0% )
 
Prev Close ( Rs.)
99.60
Open ( Rs.)
99.60
 
High ( Rs.)
99.60
Low ( Rs.)
99.60
 
Volume
384
Week Avg.Volume
15645
 
52 WK High-Low Range(Rs.)
75.9
124.45
Source DateBoard Meeting DateDetails
02-Feb-2024 12-Feb-2024 Quarterly Results
30-Oct-2023 09-Nov-2023 Quarterly Results
03-Aug-2023 11-Aug-2023 Quarterly Results
23-Jun-2023 26-Jun-2023 Inter alia, to consider and approve the appointment of : 1. Mr. Vinayak Dinesh Dendukuri (DIN: 07601309) as Additional Director designated as Whole-time Director ? Operation. 2. Mr. Upendar Mekala Reddy (DIN: 08898174) as Additional Director designated as Non-Executive Non-independent Director; 3. Mr. Krishna Yeachuri (DIN: 00066898) as Additional Director designated as Non-Executive Independent Director, and any other business with the permission of the Chair.
23-May-2023 27-May-2023 Audited Results (Revised)
17-May-2023 24-May-2023 Audited Results
05-Apr-2023 07-Apr-2023 Inter alia, to consider and approve the appointment of Company Secretary cum Compliance Officer and any other business with the permission of the Chair
01-Feb-2023 08-Feb-2023 Quarterly Results
02-Nov-2022 11-Nov-2022 Quarterly Results
04-Aug-2022 11-Aug-2022 Quarterly Results
Page 1 of 8
PREV || NEXT